Search
(+)
cartoon
dealer
buy stock illustrations
Home
My rookie portfolio
📷 Upload yours 🤳
Find results that contain
all
of your keywords. Content filter is
on
. Search will return
best illustrations, stock vectors and clipart
.
Exclude
Make it so!
You have chosen to exclude "
" from your results.
Choose orientation:
Related commercial searches:
interleukin
il
cytokine
protein
aldesleukin
recombinant
analog
used
treatment
cancer
3d
receptor
alpha
chain
Order by:
relevancy of keywords
|
publishing date
|
most downloaded
Pdb1z92
Cartoons, Illustrations & Vector Stock Images
- 12 images
Interleukin 2 (IL-2) cytokine protein. Aldesleukin is a recombinant analog of IL-2 that is used in the treatment of cancer. 3D
Interleukin 2 (IL-2) cytokine protein. Aldesleukin is a recombinant analog of IL-2 that is used in the treatment of cancer. 3D
Interleukin 2 (IL-2) cytokine protein. Aldesleukin is a recombinant analog of IL-2 that is used in the treatment of cancer. 3D
Interleukin-2 receptor alpha chain (CD25, extracellular domain). CD25 is the target of the monoclonal antibody drug daclizumab,
Interleukin-2 receptor alpha chain (CD25, extracellular domain). CD25 is the target of the monoclonal antibody drug daclizumab,
Interleukin-2 receptor alpha chain (CD25, extracellular domain). CD25 is the target of the monoclonal antibody drug daclizumab,
Interleukin 2 (IL-2) cytokine protein. Aldesleukin is a recombinant analog of IL-2 that is used in the treatment of cancer. 3D
Interleukin-2 receptor alpha chain (CD25, extracellular domain). CD25 is the target of the monoclonal antibody drug daclizumab,
Interleukin-2 receptor alpha chain (CD25, extracellular domain). CD25 is the target of the monoclonal antibody drug daclizumab,
Interleukin 2 (IL-2) cytokine protein. Aldesleukin is a recombinant analog of IL-2 that is used in the treatment of cancer. 3D
Interleukin 2 (IL-2) cytokine protein. Aldesleukin is a recombinant analog of IL-2 that is used in the treatment of cancer. 3D
Interleukin-2 receptor alpha chain (CD25, extracellular domain). CD25 is the target of the monoclonal antibody drug daclizumab,